New pulse dose setting may improve pain relief for spinal cord stimulator users
NCT ID NCT06897280
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study tests whether a new 'pulse dose' setting on an implanted spinal cord stimulator can improve pain relief and satisfaction for people with chronic, hard-to-treat back or leg pain. Participants already have a Nevro Senza or Omnia device and will try different pulse dose settings to find the lowest one that works best for them. The goal is to see if this approach can reduce pain intensity and increase comfort without losing effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- spinal cord stimulation device (MED HF10™ with pulse dose setting)
- What this could lead to
- If successful, this could offer a more effective and personalized way to manage chronic back and leg pain using an already implanted device.
- What could go wrong
- This is a small, early-phase study with only 25 participants, so results may not apply to everyone. The new setting might not provide better pain relief than current options.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC, INTRACTABLE BACK PAIN AND/OR LEG PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Neuroscience Research Center
Overland Park, Kansas, 66210, United States